Manufacturer record
Titanes Pharma: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
7 batches manufactured by Titanes Pharma (Himachal Pradesh) were declared Not of Standard Quality between October 2019 and July 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: T4500, Metronidazole Tablets IP 400 mg (exp Apr 2027). DTL Jaipur (state lab) found it not of standard quality: The sample does not conforms to the IP with respect to Dissolution. Listed in the July 2026 alert.
Records by type
7 records linked to Titanes Pharma in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Metronidazole Tablets IP 400 mg | Batch T4500Mfg Nov 2024 · Exp Apr 2027 | The sample does not conforms to the IP with respect to Dissolution.Dissolution | DTL JaipurState lab | Jul 2026 |
| Cefixime & Ofloxacin Dispersible Tablets | Batch T4646Mfg Nov 2024 · Exp Apr 2027 | The sample does not conform to the claim with respect to Assay, Uniformity of dispersion and Disintegration.Assay | DTL JaipurState lab | Jul 2026 |
| Amoxycillin and Potassium Clavilanate Oral Suspension IP | Batch TDS532Mfg Sep 2025 · Exp Aug 2027 | Assay of Amoxycillin and Pottassium ClavuanateAssay | DTL, BaddiState lab | Mar 2026 |
| Telmisartan Tab.IP 40mg | Batch T3385Mfg Feb 2024 · Exp Jan 2026 | The sample does not conform to I.P. The sample declared as Not of Standard Quality in respect of the Test Assay performed.Assay | West BengalState lab | Jan 2026 |
| Doxycycline & Lactic Acid Bacillus Tablets | Batch T4514Mfg Nov 2024 · Exp Oct 2026 | The sample does not conform to the claim with respect to Assay of Doxycycline & Description.Assay | DTL JaipurState lab | Jan 2026 |
| Cefixime and Lactic Acid Bacillus Dispersible Tablets | Batch TB020Mfg Oct 2024 · Exp Sep 2026 | Samples does not comply Assay of Cefixime as per STP.Assay | DCL TelanganaState lab | Nov 2025 |
| Metformin Hydrochloride Sustained release Tablets IP (MEFMED-SR 500 TABLETS) | Batch M500SRT-1901Mfg Jan 2019 · Exp Dec 2020 | AssayAssay | RDTL ChandigarhCDSCO lab | Oct 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.